Objective: To describe emergent therapies, such as rifaximin, nitazoxanide, intravenous immunoglobulin (IVIG), tinidazole, tolevamer, and the possible use of a vaccine, in Clostridium ...

Clorox offers a free, downloadable Clostridium difficile prevention toolkit. The toolkit contains a protocol and checklist for the terminal cleaning of C. difficile isolation rooms, information on ...

Clostridium difficile (C. diff) can cause diarrhea, stomach pain, nausea, and fever. About 1 in 6 people get a second infection within weeks. C. diff is most common in people taking antibiotics, since ...

C. diff infection can cause diarrhea. While it may lead your poop to change color, there are no specific colors that are definitive evidence of having C. diff. According to the Centers for Disease ...

Fecal transplantation through colonoscopy is an effective treatment for recurrent Clostridium difficile infection (CDI), according to a new study in Gastroenterology, the official journal of the ...

Background. Clostridium difficile infection (CDI) is the most commonly recognized cause of recurrent diarrhea. Bezlotoxumab, administered concurrently with antibiotics directed against C. difficile ...

The Food and Drug Administration has approved a fecal microbiota pill to treat recurrent infections caused by Clostridium difficile (C. diff), an antibiotic-resistant bacterium deemed an urgent threat ...

Appropriate Antibiotic Prescribing? Some Clinicians Resistant One in 10 clinicians who prescribe antibiotics without clinical certainty said the drug 'won't hurt if not needed' in a WebMD/Medscape ...

Plus, get the best of BroadwayWorld delivered to your inbox, and unlimited access to our editorial content across the globe. In the new book, "Managing a C. difficile Infection: For Patients, Families ...

Clostridium difficile is an unpleasant, sometimes severe, and potentially lethal infection. It is an enteric pathogen whose armory involves the production of a toxin leading to gut dysphoria and ...

The study of Clostridium difficile infection (CDI) continues to reveal intricate details of its pathogenesis, epidemiology and potential novel therapies. Research has elucidated how the bacterium, ...

Unfortunately, many primary care providers do not recognize antibiotic resistance and inappropriate prescribing as a problem in their office. In a recent survey, more primary care providers agreed ...